ZNF445 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.56450408184128E-11 |
Normal-vs-Stage2 |
8.88550000244237E-09 |
Normal-vs-Stage3 |
1.6304735339645E-12 |
Normal-vs-Stage4 |
1.65356617287671E-12 |
Stage1-vs-Stage2 |
3.114000E-01 |
Stage1-vs-Stage3 |
1.585590E-04 |
Stage1-vs-Stage4 |
1.398480E-03 |
Stage2-vs-Stage3 |
1.033180E-01 |
Stage2-vs-Stage4 |
1.072440E-01 |
Stage3-vs-Stage4 |
8.919800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62481139653892E-12 |
Normal-vs-AfricanAmerican |
6.5848000052604E-08 |
Normal-vs-Asian |
2.275000E-01 |
Caucasian-vs-AfricanAmerican |
6.496000E-01 |
Caucasian-vs-Asian |
6.054000E-02 |
AfricanAmerican-vs-Asian |
1.435220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.33066907387547E-16 |
Normal-vs-Female |
1.48060452787036E-11 |
Male-vs-Female |
4.353600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.46410000000119E-05 |
Normal-vs-Age(41-60Yrs) |
1.95554683557475E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
1.83760000549427E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.741400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.555200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.497500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.324300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.254200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.006820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.316220E-01 |
Normal-vs-Grade 2 |
1.05470077116365E-11 |
Normal-vs-Grade 3 |
1.06026298851702E-13 |
Normal-vs-Grade 4 |
1.63835611743934E-12 |
Grade 1-vs-Grade 2 |
6.564100E-02 |
Grade 1-vs-Grade 3 |
2.704200E-03 |
Grade 1-vs-Grade 4 |
4.998000E-04 |
Grade 2-vs-Grade 3 |
1.135790E-02 |
Grade 2-vs-Grade 4 |
2.141100E-03 |
Grade 3-vs-Grade 4 |
1.598760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.59829943619161E-11 |
Normal-vs-ccB subtype |
4.74500438940595E-11 |
ccA subtype-vs-ccB subtype |
8.251000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63757896132211E-12 |
Normal-vs-N1 |
1.73494999999857E-05 |
N0-vs-N1 |
2.918200E-01 |
|
|